Why I invested in Tactogen
MDMA is a wonderful medicine. This startup company wants to make it even better.
Published in
6 min readMay 2, 2023
Psychedelic medicines are generating excitement everywhere — among academic researchers and therapists, in the press, even with members of Congress — everywhere, that is, but among investors. Several startups developing psychedelic therapies have gone bust. Shares in others sell for…